Page last updated: 2024-08-05 11:13:46

primary arylamine

A primary amine formally derived from ammonia by replacing one hydrogen atom by an aryl group. R-NH2 where R is an aryl group.

ChEBI ID: 50471

Members (16)

MemberDefinitionRole
1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazineA N-arylpiperazine that is piperazine substituted by 2-(4-aminophenyl)ethyl and 3-(trifluoromethyl)phenyl groups at positions 1 and 4, respectively. It is a selective 5-HT1A serotonin receptor agonist and 5-HT1D serotonin receptor antagonist.LY-165163
2-(1H-benzimidazol-2-yl)anilineA member of the class of benzimidazoles that is 1H-benzimidazole substituted by a 2-aminophenyl group at position 2.2-(1H-benzimidazol-2-yl)aniline
2-fluoroanilineA derivative of aniline in which the hydrogen at position 2 has been substituted by fluorine. It is used as a pharmaceutical intermediate2-fluoroaniline
2,4-xylidineA primary arylamine that is aniline in which the hydrogens at the 2- and 4-positions are replaced by methyl groups. A clear to yellow liquid, it is used in production of certain dyes, pesticides and other chemicals.2,4-dimethylaniline
2,5-xylideneA primary arylamine that is aniline in which the hydrogens at the 2- and 5-positions are replaced by methyl groups. It is used in the manufacture of dyes and other chemicals.2,5-dimethylaniline
2,6-xylidineA primary arylamine that is aniline in which the hydrogens at the 2- and 6-positions are replaced by methyl groups. It is used in the production of some anasthetics and other chemicals. It is a drug metabolite of lidocaine (local anasthetic).2,6-dimethylaniline
3-fluoroanilineA derivative of aniline in which the hydrogen at position 3 has been substituted by fluorine. It is used as a pharmaceutical intermediate.3-fluoroaniline
3,4-xylidineA primary arylamine that is aniline in which the hydrogens at the 3- and 4-positions are replaced by methyl groups. A low-melting, crystalline solid, it is used in the production of vitamin B2, dyes, pesticides and other chemicals.3,4-dimethylaniline
4-fluoroanilineA primary arylamine that is the derivative of aniline in which the hydrogen at position 4 has been substituted by fluorine. It is used as an intermediate in the manufacture of pharmaceuticals, herbicides and plant growth regulators.4-fluoroaniline
ameziniumA pyridazinium ion that is pyridazin-1-ium which is substituted by a phenyl, amino and methoxy groups at positions 1, 4 and 6, respectively.amezinium
anilineA primary arylamine in which an amino functional group is substituted for one of the benzene hydrogens.aniline
clenbuterolA substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.clenbuterol
disperse orange 3Azobenzene substituted at the phenyl 4-positions by an amino and a nitro group.4-(4-nitrophenylazo)aniline
ferrostatin-1An ethyl ester resulting from the formal condensation of the carboxy group of 3-amino-4-(cyclohexylamino)benzoic acid with ethanol. It is a potent inhibitor of ferroptosis, a distinct non-apoptotic form of cell death caused by lipid peroxidation. It is also a radical-trapping antioxidant and has the ability to reduce the accumulation of lipid peroxides and chain-carrying peroxyl radicals.ferrostatin-1
lamotrigineA member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6.lamotrigine
pd 166866A member of the class of pyridopyrimidines that is pyrido[2,3-d]pyrimidine substituted by an amino group at position 2, 3,5-dimethoxyphenyl group at position 6, and by a (tert-butylcarbamoyl)nitrilo group at position 7. It is a selective ATP competitive inhibitor of the human fibroblast growth factor-1 receptor (FGFR1) tyrosine kinase with an IC50 of 52.4 nM.PD-166866

Research

Studies (7,274)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990926 (12.73)18.7374
1990's1,228 (16.88)18.2507
2000's2,183 (30.01)29.6817
2010's2,218 (30.49)24.3611
2020's719 (9.88)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials605 (7.81%)5.53%
Reviews695 (8.97%)6.00%
Case Studies773 (9.97%)4.05%
Observational42 (0.54%)0.25%
Other5,636 (72.71%)84.16%